A volunteer has died during trial of COVID-19 vaccine developed by AstraZeneca and Oxford University. No further details were provided citing medical confidentiality of those involved in trials. After the news broke out AstraZeneca shares fell 1.7%.
Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University had died but added that the trial would continue despite the death.
Oxford confirmed the plan to keep testing, saying in a statement that after careful assessment “there have been no concerns about safety of the clinical trial.”
Avisa provided no further details, citing medical confidentiality of those involved in trials.
Meanwhile, as soon as the news broke out, AstraZeneca shares fell 1.7%.
Earlier, drug giant AstraZeneca had stopped global trials of its coronavirus vaccine after it caused a mysterious illness in one of the volunteers. The company said it is investigating the cause of the unexplained illness but did not say who had stopped the trial. The mysterious illness is reported to be an inflammatory syndrome known as transverse myelitis which may lead to paralysis.
A senior executive of AstraZeneca has revealed in shocking details that the company could not be on receiving end of any constitutional motion or face legal action for any possible side effects or unwanted reactions induced by its Covid-19 vaccine.https://t.co/Q53SPaHuJ5
— GreatGameIndia (@GreatGameIndia) August 4, 2020
There is a lot of unrest and distrust among people with regards to the COVID-19 vaccine and regulators and companies alike have been working to ensure people trust in the vaccine authorization process.
However, as reported by GreatGameIndia earlier, a senior managerial executive of AstraZeneca has revealed in shocking details that the company could not be on the receiving end of any constitutional motion or face legal action for any possible side effects or unwanted reactions induced by its Covid-19 vaccine.
The company has agreements with governments as per which AstraZeneca cannot be held responsible for any side-effects of the vaccine and those affected will have no legal recourse.
AstraZeneca has been granted protection from future product liability claims related to its COVID-19 vaccine by most of the countries with which it has struck supply agreements.
For latest updates on the outbreak check out our Coronavirus Coverage.